NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
key details
| Value | £626,522,476 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 23 Apr 2024 |
| Contract start | 1 Nov 2024 |
| Contract end | 31 Oct 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-7ebc8e72-38c5-4910-9915-28bc0d6ff58a |
Awards (13)
This procurement was awarded to 13 suppliers. Values shown are per-award; the notice total is £626,522,476.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £626,522,476 | 28 Oct 2024 | active |
| Amarox Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Gilead Sciences Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Janssen-Cilag Ltd shared | £626,522,476 | 28 Oct 2024 | active |
| Lupin Healthcare (UK) Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Macleods Pharma UK Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Mawdsley-Brooks & Co Ltd shared | £626,522,476 | 28 Oct 2024 | active |
| Merck Sharpe & Dohme (UK) Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Milpharm Ltd/aurobinbdo Primary shared | £626,522,476 | 28 Oct 2024 | active |
| MSN Laboratories Europe Limited shared | £626,522,476 | 28 Oct 2024 | active |
| Mylan shared | £626,522,476 | 28 Oct 2024 | active |
| ViiV Healthcare UK Ltd shared | £626,522,476 | 28 Oct 2024 | active |
description
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024
Offer reference number: CM/PHS/24/5709
Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 28 Nov 2024 | Award (award) | · | 3962cf6d-defc-483f-82d9-ecdb0cf87a40-806476 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.